# TP53 and IGHV Mutations in Chronic Lymphocytic Leukemia (CLL) in Tanzania

## Project Overview

This repository contains research materials, data analysis scripts, and documentation for the study of **TP53** and **IGHV** (Immunoglobulin Heavy Variable) gene mutations in **Chronic Lymphocytic Leukemia (CLL)** patients in Tanzania.

## ğŸ§¬ Research Focus

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia in Western countries, but its prevalence and genetic characteristics in sub-Saharan Africa, particularly Tanzania, remain understudied. This project aims to:

- **Analyze TP53 mutations** in Tanzanian CLL patients
- **Study IGHV gene usage patterns** and mutation status
- **Compare findings** with international CLL cohorts
- **Identify population-specific genetic variants** that may influence treatment response
- **Develop targeted treatment strategies** for resource-limited settings

## ğŸ¯ Objectives

### Primary Objectives
1. **Characterize TP53 mutation frequency** in Tanzanian CLL patients
2. **Determine IGHV mutation status** and gene usage patterns
3. **Correlate genetic findings** with clinical outcomes
4. **Assess prognostic implications** of identified mutations

### Secondary Objectives
1. **Develop cost-effective screening methods** for TP53 and IGHV testing
2. **Create population-specific reference data** for Tanzanian CLL patients
3. **Establish collaborative networks** for ongoing CLL research in East Africa
4. **Train local researchers** in molecular diagnostic techniques

## ğŸ§ª Methodology

### Sample Collection
- **Patient recruitment** from Muhimbili National Hospital and affiliated centers
- **Ethical approval** from institutional review boards
- **Informed consent** from all participants
- **Sample processing** and DNA extraction

### Molecular Analysis
- **Next-Generation Sequencing (NGS)** for comprehensive mutation analysis
- **Sanger sequencing** for validation of key mutations
- **IGHV gene rearrangement analysis** using established protocols
- **Bioinformatics pipeline** for variant calling and annotation

### Statistical Analysis
- **Descriptive statistics** for mutation frequencies
- **Survival analysis** for prognostic assessment
- **Comparative analysis** with international datasets
- **Population genetics** analysis for ancestry assessment

## ğŸ“ Repository Structure

```
TP53-IGHV-CLL-Tanzania/
â”œâ”€â”€ data/                    # Clinical and molecular data
â”œâ”€â”€ scripts/                 # Analysis scripts and utilities
â”‚   â”œâ”€â”€ qr_generator.py     # QR code generator for presentations
â”‚   â”œâ”€â”€ mutation_analysis.R # R scripts for mutation analysis
â”‚   â””â”€â”€ survival_analysis.R # Survival and prognostic analysis
â”œâ”€â”€ docs/                   # Documentation and protocols
â”œâ”€â”€ presentations/          # Conference presentations and posters
â”œâ”€â”€ images/                 # QR codes, figures, and diagrams
â””â”€â”€ README.md              # This file
```

## ğŸ› ï¸ Tools and Technologies

### Laboratory Techniques
- **DNA extraction** from peripheral blood samples
- **PCR amplification** of target regions
- **NGS library preparation** and sequencing
- **Capillary electrophoresis** for fragment analysis

### Bioinformatics Tools
- **R/Bioconductor** for statistical analysis
- **Python** for data processing and visualization
- **IGMT/V-QUEST** for IGHV analysis
- **COSMIC database** for mutation annotation
- **Custom scripts** for population-specific analysis

## ğŸ“Š Expected Outcomes

1. **Comprehensive mutation profile** of TP53 in Tanzanian CLL patients
2. **IGHV gene usage patterns** specific to the East African population
3. **Clinical correlations** between genetic findings and patient outcomes
4. **Therapeutic recommendations** based on molecular findings
5. **Research publications** in peer-reviewed journals
6. **Capacity building** for molecular diagnostics in Tanzania

## ğŸ¤ Collaborations

- **Muhimbili University of Health and Applied Sciences** (MUHAS)
- **Muhimbili National Hospital** (MNH)
- **International CLL research consortiums**
- **African Society of Human Genetics** (AfSHG)

## ğŸ“ Contact Information

**Principal Investigator:** Collin Nzunda  
**Institution:** Muhimbili University of Health and Applied Sciences  
**Email:** [collin.nzunda@muhas.ac.tz]  
**LinkedIn:** [linkedin.com/in/collinnzunda](https://linkedin.com/in/collinnzunda)  
**Twitter/X:** [@CollinNzunda](https://x.com/CollinNzunda)

## ğŸ“‹ Ethics and Compliance

This research is conducted in accordance with:
- **Declaration of Helsinki** principles
- **Local institutional** review board approvals
- **Tanzanian health research** regulations
- **International guidelines** for genetic research

## ğŸ“š References

1. Hallek, M. (2019). Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. *American Journal of Hematology*, 94(11), 1266-1287.

2. Rossi, D., & Gaidano, G. (2016). The clinical impact of gene mutations in chronic lymphocytic leukemia. *Blood*, 127(8), 953-962.

3. Agathangelidis, A., et al. (2019). Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. *Blood*, 134(6), 544-554.

---

## ğŸ·ï¸ QR Code for Easy Access

![QR Code for Repository](images/tp53_project_qr.png)

*Scan this QR code to access the complete repository*

---

**Last Updated:** September 2024  
**Version:** 1.0.0  
**License:** [Specify license for data sharing and usage]